| Patents for C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144) |
|---|
| 02/23/2005 | CN1585152A Current carrier transmtiting material with high-effect and balancing electronic cavity transmitting performance |
| 02/23/2005 | CN1190434C Novel heterocyclic compounds and process for its preparation, and pharmaceutical compositions containing them and their use in treatment of diabetes and related diseases |
| 02/17/2005 | WO2005014563A1 Piperazine with or-substituted phenyl group and their use as glyt1 inhibitors |
| 02/17/2005 | WO2005013888A2 Compounds, compositions and methods |
| 02/17/2005 | WO2004002491A8 Morpholine and tetrahydropyran drivatives and their use as cathepsin inhibitors |
| 02/17/2005 | CA2534675A1 Piperazine with or-substituted phenyl group and their use as glyt1 inhibitors |
| 02/16/2005 | EP1506991A2 Liquid crystalline compound, liquid crystalline composition and retardation film |
| 02/16/2005 | EP1505968A1 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes |
| 02/10/2005 | WO2005012241A2 p-38 KINASE INHIBITORS |
| 02/10/2005 | CA2534990A1 P-38 kinase inhibitors |
| 02/09/2005 | EP1503997A1 Cysteine protease inhibitors |
| 02/09/2005 | CN1578663A Inhibitors of histone deacetylase |
| 02/09/2005 | CN1188411C Oxime derivatives and agricultural chemicals containing same |
| 02/08/2005 | US6852719 Glucocorticoid receptor modulators |
| 02/03/2005 | WO2005009998A1 Pna monomer and precursor |
| 02/03/2005 | WO2005009941A1 Indane derivates as muscarinic receptor agonists |
| 02/03/2005 | US20050026930 1,3,4-Thiadiazole-2-sulfonyl-N-piperazine; 1,3,4-oxadiazole-2-sulfonyl-N-piperazine; oxazole-2-sulfonyl-N-piperazine; or thiazole-2-sulfonyl-N-piperazine derivatives; cyclization, coupling, amidation; peptide synthesis; peptide nucleic acids |
| 02/03/2005 | US20050026929 2-Phenyl-4-(piperidin-1-ylcarbonyl)-oxazole derivatives; capsase activators; cancer, autoimmune diseases, rheumatoid arthritis, inflammatory bowel disease, or psoriasis |
| 02/03/2005 | US20050025997 Luminescent layer between electrodes |
| 02/03/2005 | CA2529036A1 Indane derivates as muscarinic receptor agonists |
| 02/02/2005 | EP1501787A1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists |
| 01/27/2005 | WO2004064972A3 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| 01/27/2005 | US20050020634 Acat inhibitors; cardiovascular disorders; restenosis; Alzheimer's disease |
| 01/27/2005 | US20050020590 Antiinflammatory agents; autoimmune disease; bone disorders; viricides; antiproliferative agents; antiarthritic agents |
| 01/27/2005 | US20050020584 Benzamide derivatives as antagonists of orexin receptors |
| 01/26/2005 | EP1499600A1 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 01/26/2005 | EP0983267B1 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 01/20/2005 | WO2005005437A1 An improved process for the manufacture of isradipine. |
| 01/20/2005 | US20050014804 Tetrazole and oxadiazolone substituted beta-amino acid derivatives |
| 01/20/2005 | US20050014787 5-amidino-2-hydroxybenzenesulfonamide derivatives medicinal compoistions containing the same medicinal use thereof and intermediates in the production thereof |
| 01/20/2005 | US20050014769 Anticancer agents; controlling apoptosis |
| 01/19/2005 | EP1497270A1 Amide compounds and methods of using the same |
| 01/19/2005 | CN1566096A Prostaglandin agonists and their use to treat bonedisorders |
| 01/13/2005 | WO2005003081A2 Sulfonimide containing compounds and their use in polymer electrolyte membranes for electrochemical cells |
| 01/12/2005 | EP1494997A1 Substituted aryl amides |
| 01/12/2005 | EP1494989A2 Compounds that modulate ppar activity and methods for their preparation |
| 01/12/2005 | EP1171423B1 Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands |
| 01/12/2005 | CN1564811A Acylsulfonamides as inhibitors of steroid sulfatase |
| 01/06/2005 | WO2005001979A2 Fluorinated sulfonamide compounds and polymer electrolyte membranes pepared therefrom for use in electrochemical cells |
| 01/06/2005 | WO2005000298A2 5-membered heterocycle-based p-38 inhibitors |
| 01/06/2005 | US20050004186 Phenyl-(2-[1,3,4]thiadiazol-2-yl-phenyl)-amine and (2-[1,3,4]Oxadiazol-2-yl-phenyl)phenyl-amine derivatives; immunomodulators; inflammation, proliferative diseases |
| 01/06/2005 | CA2528438A1 P-38 inhibitors |
| 01/05/2005 | EP1492756A1 Novel thyroid receptor ligands |
| 01/05/2005 | CN1183113C Tri-aryl acid derivatives as PPAR receptor ligands |
| 01/04/2005 | US6838484 Androgen receptor targeting agents which demonstrate androgenic and anabolic activity of a nonsteroidal ligand for the androgen receptor |
| 01/04/2005 | US6838466 Compounds for the treatment of inflammatory disorders |
| 01/04/2005 | CA2106897C Use of substituted 1,2,4-oxadiazole derivatives for combating endoparasites, new substituted 1,2,4-oxadiazole derivatives, and processes for their preparation |
| 12/30/2004 | US20040267015 Bactericides |
| 12/30/2004 | US20040266839 2'-Methyl-5-(1,3,4-oxadiazol-2-yl)1,1'-biphenyl-4-carboxaide derivatives and their use as p38 kinase inhibitors |
| 12/29/2004 | WO2004091502A3 1,2,4-oxadiazole benzoic acid compounds |
| 12/29/2004 | EP1491524A2 Selective androgen receptor modulators and methods of use thereof |
| 12/29/2004 | EP1491190A1 Decomposition inhibitor for extracellular matrix of cartilage |
| 12/29/2004 | EP1491187A1 Preventive or therapeutic agent for kidney disease |
| 12/29/2004 | EP0986545B1 Non-steroidal (hetero) cyclically substituted acylanilides with mixed gestagen and androgen activity |
| 12/23/2004 | WO2004080958A3 Process to tetrahydrotriazolopyrazines and intermediates |
| 12/23/2004 | US20040259804 (Substituted)Acyl dipeptidyl inhibitors of the ICE/ced-3 family of cysteine proteases |
| 12/22/2004 | EP1487843A2 Substituted phenylacetic acids |
| 12/22/2004 | EP1487828A2 Morpholinyl-urea derivatives for use of the treatment of inflamatory diseases |
| 12/22/2004 | EP1487785A2 Novel florfenicol-type antibiotics |
| 12/22/2004 | EP1487430A1 Methods for treating diseases related to intraocular pressure |
| 12/22/2004 | EP1373264B1 3-heterocyclylpropanohydroxamic acid as procollagen c-proteinase inhibitors |
| 12/22/2004 | EP1051172B1 Method for treating copd |
| 12/21/2004 | US6833200 Luminescent device with a triarylamine compound |
| 12/16/2004 | WO2004108663A1 N-alkynyl-2- (substituted aryloxy) alkylthioamide derivatives as fungicides |
| 12/16/2004 | WO2004108661A1 Amidino compounds as cysteine protease inhibitors |
| 12/16/2004 | WO2004096948A8 Electron transport agents for organic electronic devices |
| 12/16/2004 | WO2003063797A8 Cycloalkyl inhibitors of potassium channel function |
| 12/16/2004 | US20040254236 Antiinflammatory agents; moderate cytokine activity; bone disorders autoimmune disease; neurodegenerative diseases; viricides; asthma; antiallergens; adult respiratory distress syndrome; antiarthritic agents; antidiabetic agents |
| 12/16/2004 | US20040254227 prevent reproduction of herpes c virus; viricides; antiproliferative agents; prevention infections |
| 12/16/2004 | CA2527313A1 N-alkynyl-2-(substituted aryloxy) alkylthioamide derivatives as fungicides |
| 12/16/2004 | CA2526694A1 Amidino compounds as cysteine protease inhibitors |
| 12/15/2004 | EP1486486A2 Substituted B-thiocarboxylic acids |
| 12/15/2004 | EP1485107A1 Phospholipids as caspase inhibitor prodrugs |
| 12/14/2004 | US6831088 3-heterocyclypropanohydroxamic acid PCP inhibitors |
| 12/14/2004 | CA2235146C Herbicidal sulfonamides |
| 12/09/2004 | US20040248950 Apo ai expression accelerating agent |
| 12/09/2004 | US20040248740 for controlling undesirable plants |
| 12/08/2004 | EP1482929A1 Use of substituted 3-phenyl-5-alkoxy-1,3,4-oxdiazole-2-one for producing medicaments that inhibit pancreatic lipase |
| 12/08/2004 | EP1482924A2 Cathepsin cysteine protease inhibitors |
| 12/08/2004 | EP1240152B1 Ox(adi)azolyl-hydroxamic acids useful as procollagen c-proteinase inhibitors |
| 12/02/2004 | WO2004103366A1 Heterocyclic compounds useful to treat hcv |
| 12/02/2004 | DE10320326A1 New 1-benzoyl-3-(heterocyclyl-phenyl)-urea derivatives, are glycogen phosphorylase a inhibitors useful e.g. for treating type II diabetes, dyslipidemia or arteriosclerosis |
| 12/01/2004 | EP1480960A1 Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, the production thereof and their use in medicaments |
| 12/01/2004 | EP1480957A1 Hppars activators |
| 12/01/2004 | EP1480948A1 Semicarbazide derivatives and their use as antithrombotics |
| 12/01/2004 | EP0977745B1 Thioaryl sulfonamide hydroxamic acid compounds |
| 12/01/2004 | CN1550491A Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides |
| 12/01/2004 | CN1177838C 2,5-substituting-1,3,4-oxadiazole compound and its preparation and application |
| 12/01/2004 | CN1177830C Benzoheterocycles and their use as MEK inhibitors |
| 11/30/2004 | US6825192 Non-n-methyl-d-aspartate (non- nmda) excitatory amino acid receptor antagonistic action, for example 2-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (ampa) receptor antagonistic action |
| 11/25/2004 | WO2004101537A1 Metalloproteinase inhibitors |
| 11/25/2004 | WO2004083194B1 Blue light-emitting compound, method for producing same and light-emitting device utilizing same |
| 11/25/2004 | US20040236112 Hepatitis C Virus (HCV); antiproliferative agents; replication-defective |
| 11/25/2004 | US20040235913 drug abuse; psychological disorders; antidepressants; sexual disorders; hypotensive agents; anxiolytic agernts; Alzheimer's disease; schizophrenia; Parkinson's disease; sleep disorders; reastless leg syndrome; irritable bowel syndrome |
| 11/25/2004 | US20040235912 preventing, treating diabetes mellitus, Syndrome X, cardiovascular disease , hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis in a mammal |
| 11/25/2004 | US20040235870 Protein kinase inhibitors |
| 11/23/2004 | US6821972 3-heterocyclylpropanohydroxamic acid PCP inhibitors |
| 11/23/2004 | US6821960 Glucagon antagonists/inverse agonists |
| 11/18/2004 | WO2004099165A2 Heterocyclic compounds and hydro isomers thereof |
| 11/18/2004 | US20040226108 7-Nitro-2,1,3-benzoxadiazole and 7-nitro-2,1,3-benzthiadiazole derivatives, as well dyeing agents for keratin fibers containing these compounds |